← European Medicine Shortage Tracker · all medicines

Testosterone pharma shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Testosterone pharma currently has availability issues reported in 1 European register: Greece.

Limited availability  ATC G03BA03 · also listed as: TESTOSTERONE PHARMA · data refreshed 11 September 2026

Key facts

As of 11 September 2026, 1 of the 9 tracked registers list current availability issues for Testosterone pharma, covering 1 affected product presentation. The longest-running open report was filed in Greece on 2026-07-20 and has now been open for about 2 months. Where agencies state a cause, delivery delays lead with 1 of the 1 stated-cause reports. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. In the WHO ATC classification, Testosterone pharma is coded G03BA03 — a medicine acting on the genito-urinary system and sex hormones — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇬🇷 GreeceLimited availability
TOSTRAN GEL.EXT.US 2% W/W BTx 1 canister x60 G
2026-07-202026-08-20Εναλλακτικά άλλο σκεύασμα της ίδιας δραστικής και μορφής Καθυστέρηση πregister ↗

Full report history (1 register entry)

Every individual register entry for Testosterone pharma in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇬🇷 GRTOSTRAN GEL.EXT.US 2% W/W BTx 1 canister x60 GLimited availability2026-07-202026-08-20Εναλλακτικά άλλο σκεύασμα της ίδιας δραστικής και μορφής Καθ

Frequently asked

Is Testosterone pharma currently in shortage in Europe?

Yes. As of 11 September 2026, availability issues are reported in: Greece. Availability is national — a shortage in one country does not mean it is short everywhere.

Where does this Testosterone pharma availability data come from?

Directly from the official medicines-agency register that lists Testosterone pharma: EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Testosterone pharma — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/testosterone-pharma/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Testosterone pharma availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/testosterone-pharma/">Testosterone pharma shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Testosterone pharma: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 11 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.